News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Transformative study for 1st line Metastatic HER2+ Breast Cancer at ASCO25
Sara Tolaney/X
Jun 4, 2025, 09:58

Transformative study for 1st line Metastatic HER2+ Breast Cancer at ASCO25

Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared a post on LinkedIn:

“Congratulations to Dr. Sara Tolaney, Dana-Farber Cancer Institute and the Destiny Breast09 investigators for a Trasnformative study for 1st line metastatic HER2+ breast cancer at ASCO25.
Really enjoyed talking to Dr. Giuseppe Curigliano on the HER2 story that started in Orlando about 20 years ago.”

Chandler Park acknowledged the impact of the DESTINY-Breast09 trial presented at ASCO 2025, recognizing Dr. Sara Tolaney and the investigative team for advancing treatment in first-line metastatic HER2-positive breast cancer.

More posts featuring Chandler Park.

ASCO25 Breast Cancer cancer Chandler Park Dana-Farber Cancer Institute DESTINY-Breast09 fight against cancer Giuseppe Curigliano Global fight against cancer HER2 Metastatic HER2+ Breast Cancer OncoDaily Oncology Orlando Sara Tolaney University of Louisville School of Medicin
Special Coverage
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025
Blog
Jun 4, 2025, 15:45
Teresa Amaral: Honored to Present Streamlining Clinical Research Project by ESMO, ASCO, and ESMO Industry Strategic Forum
Insight
Jun 4, 2025, 14:21
Princess Adila: Her Royal Highness, Her Human Mission - CancerWorld
Blog
Jun 4, 2025, 13:42
Florez Lab Presented The EQUAL Study at ASCO25
Blog
Jun 4, 2025, 12:52
Amy Peterson Shares Personal Reflections and Call to Support Cancer Research at ASCO 2025